Position in ACHV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$660,741
-$481,756 QoQ
Shares Held
224,742
-2.2% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 81 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,611,306,665 across 416 Biotechnology names. ACHV ranks #250 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in ACHV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $660,741 | 224,742 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,142,497 | 229,879 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $691,251 | 219,445 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $487,809 | 215,845 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,078,664 | 403,995 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,467,120 | 416,796 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,768,559 | 373,114 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $593,482 | 126,273 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $449,230 | 98,732 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $420,173 | 101,984 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $339,515 | 78,957 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $381,869 | 73,578 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $216,954 | 31,905 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $40,287 | 16,444 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $54,265 | 16,444 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $81,539 | 16,709 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $129,439 | 17,099 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $132,368 | 17,014 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $147,151 | 17,312 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $153,522 | 17,096 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||